Senior Segment Marketing Manager – Biopharma
Danaher Corporation
Summary
The Senior Segment Marketing Manager owns Biopharma segment strategy, positioning, brand development, external expert networks, content strategy, and commercial enablement. This position reports to the head of Biopharma product marketing, sits on the Global Strategic Marketing team, and is fully remote.
Job description
Own global Biopharma segment GTM strategy
- Define priority customer groups, workflows, applications, market opportunities, value propositions, and routes to growth.
- Translate customer, market, competitive, regulatory, and funding insights into clear strategic choices, business cases, and commercial priorities.
- Identify unmet needs and portfolio or solution gaps that inform commercialization, innovation, partnership, and investment decisions.
Build the BEC LS brand in Biopharma
- Develop a differentiated segment narrative that connects BEC LS capabilities to critical Biopharma workflows and customer outcomes.
- Build awareness, relevance, consideration, and preference across priority Biopharma audiences through focused brand and thought-leadership programs.
- Partner with Digital and Commercial Marketing to activate customer-centric campaigns and demand-generation initiatives.
Develop and activate external expert networks
- Build a global network of key opinion leaders, scientific experts, industry partners, and customer champions to strengthen market insight and credibility.
- Create advisory activities, scientific collaborations, and external engagement plans aligned with priority growth opportunities.
- Translate expert and customer input into actionable segment, content, and commercial recommendations.
Enable commercial teams and drive measurable funnel
- Own the Biopharma content and asset roadmap.
- Develop customer-facing content, workflow narratives, proof points, application stories, campaigns, playbooks, and competitive tools.
- Equip sales teams with segment knowledge, discovery questions, value messaging, training, and tools that support confident customer conversations and improved conversion.
Lead go-to-market execution and performance management
- Lead global, cross-functional commercialization programs from opportunity definition through activation, adoption, and scale-up.
- Align global and regional stakeholders around priorities, roles, execution plans, and performance expectations.
- Track awareness, engagement, FFR, qualified funnel, sales adoption, pipeline progression, win rate, and revenue contribution; use results to improve programs and investment decisions.
Requirements
- Master's degree in Life Sciences, Biotechnology, Bioprocessing, Marketing, Business, or a related scientific discipline.
- 8+ years of experience in strategic marketing, segment marketing, product marketing, market development, commercial strategy, or related life sciences commercial roles.
- Demonstrated experience in the Biopharma market, including customer workflows, applications, buying processes, and commercialization within bioprocessing, biologics, cell and gene therapy, analytical instrumentation, or related markets.
- Experience developing and executing customer insight programs, including Voice of Customer research, customer interviews, advisory boards, market research, and win/loss analysis.
- Demonstrated success developing and commercializing go-to-market strategies, value propositions, content strategies, sales enablement programs, and growth initiatives in a global B2B environment.
- Ability to travel up to 35% globally, including customer engagements, scientific conferences, advisory boards, commercial meetings, and business planning activities.
Benefits
- Paid time off
- Medical insurance
- Dental insurance
- Vision insurance
- 401(k)
- Bonus/incentive pay
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.